Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR125844 in MET-amplified NSCLC
NCT02435121Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SAR125844 in non-small cell lung cancer (NSCLC), sponsored by Sanofi. Started Nov 2015; status: completed.
02
Drugs
SAR125844
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02435121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02435121.